Prostate Cancer — An Interview with Prof Karim Fizazi

Oncology Today with Dr Neil Love · Oct 23, 2026 · 1h 1m

Featuring an interview with Prof Karim Fizazi, including the following topics:

Perspectives on the PROTEUS Phase III trial evaluating the addition of apalutamide to standard therapy for high-risk localized prostate cancer (0:00)

Mechanism of action of opevesostat and potential role in castration-resistant prostate cancer with androgen receptor mutations (15:37)

Perspectives on alpha- and beta-emitting radiopharmaceuticals in the treatment of prostate cancer (22:47)

Novel antibody-drug conjugates and proteolysis-targeting chimeras (30:43)

Treatment approaches for metastatic hormone-sensitive…